NASDAQ
CGEN
Last Price
US $2.30
KEY FIGURES
MKT CAP
$217.5M
EPS
TTM
$0.37
PEG
TTM
0.24x
P/E
TTM
6.24x
P/S
TTM
2.99x
YIELD
0.00%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
47.72%
Return on equity
ROIC: 24.67%
Valuation History
6.5X
Price to Earnings
EV/EBITDA: 6.2X
Cash flow
Profit margin
105.20%
(FY vs FY)
EBITDA Y/Y
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $2.30
—
Default assumptions
EBITDA Multiple
Fair Value
Market $2.30
43.04%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Compugen Ltd. cash flow to debt ratio of 1.07K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial risk - Healthy cash flow growth.
Compugen Ltd.'s free cash flow has decreased -36.69% from $49.49M last year to $31.33M, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Compugen Ltd.'s debt to equity ratio is 0.03, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Compugen Ltd.'s debt has decreased relative to shareholder equity from 0.05 last year to 0.03 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Compugen Ltd. has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Compugen Ltd. earns at least as much interest as it pays. Interest obligations are fully covered.
Financial stability - Profit margin growth.
Compugen Ltd.'s profit margin has increased (-193.93%) in the last year from -51.07% to 47.97%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Compugen Ltd.'s short-term assets of $148.02M exceed its short-term liabilities of $22.57M
Increasing performance - ROA.
Compugen Ltd.'s return on assets of 23.90% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
Compugen Ltd.'s return on equity of 47.72%, is higher than 15.00%, indicating good performance
Decreasing performance - Earnings quality.
Compugen Ltd.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Compugen Ltd. had positive net income in only 1.00 out of 5 years, indicating unstable earnings
Increasing performance - Free cash flow.
Compugen Ltd. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Compugen Ltd. has a free cash flow yield of 14.41%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Compugen Ltd.'s yearly earnings has increased -348.35% since last year from $-14.23M to $35.34M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Compugen Ltd.'s yearly revenue has increased 161.14% since last year from $27.86M to $72.76M, signaling increasing performance
Increasing performance - ROIC.
ROIC 24.67% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
Compugen Ltd.'s 3-year revenue CAGR of 113.28% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Compugen Ltd. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Compugen Ltd. had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Compugen Ltd. has insufficient data to evaluate this check.
Undervalued - Earnings yield.
Compugen Ltd. has an earnings yield of 16.03%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Undervalued - EBITDA valuation.
Compugen Ltd. is undervalued relative to its fair value price of 3.29 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Compugen Ltd. has an EV/EBITDA ratio of 3.62x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Compugen Ltd. has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Compugen Ltd. has a price-to-book ratio of 2.28x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Compugen Ltd. has a price-to-sales ratio of 2.99x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue